Recently re-established as a network member of PSI, PSI/Uganda runs health interventions in reproductive health and youth friendly services, as well as socially markets products, services and healthy behaviors that enable low-income and vulnerable communities to lead healthier lives.
Women’s Health Project
PSI is implementing the Women’s Health Project (WHP) in Uganda to increase access to and demand for affordable, high quality long-term family planning services through a network of over 175 privately owned health clinics.
The goal of the program is to reduce maternal mortality by improving the quality of reproductive health services, limiting births through increased use of long-term family planning, and providing harm reduction in the case of unsafe abortions through training health providers.
Cervical Cancer Screening and Preventive Treatment
PSI/Uganda is supporting 100 privately owned clinics within the ProFam franchise to provide cervical cancer screening using visual inspection with acetic acid (VIA) at an affordable price. Currently, 35 of these clinics have a cryotherapy machine, acting as referral sites for early treatment for cervical cancer. A pilot for HPV-DNA testing in two districts of Mbale and Soroti has also been carried out.
Youth Friendly Services (YFS) Project
PSI/Uganda is implementing a youth-friendly program using the private sector to reach girls aged 15-24 with sexual and reproductive health information and services. This project is being implemented in the districts of Wakiso, Mukono, Buikwe and Kampala in the private sector. In order to come up with a highly impactful intervention, PSI/Uganda is using the human centered design process to understand what young people want and need, and how to provide a friendly environment for them to access and use sexual and reproductive health information and services.
Maternal and Newborn Health
Clean Delivery Kits
PSI/Uganda distributes clean delivery kits for mothers, containing essential items for safe delivery. The Maama kit has been expanded to include chlorhexidine for newborn umbilical cord care following approval by the Ministry of Health. The Maama Kit is primarily purchased by relief agencies working with refugees and other priority populations, but is also sold through pharmacies.
PSI/Uganda is also socially marketing Misoprostol and Umbi-gel (chlorhexidine) to ensure that every mother has a chance to protect her life and that of her newborn baby.
Water, Sanitation and Hygiene
P&G Purifier of Water
PSI/Uganda socially markets P&G Purifier of Water, formerly, PuR; an affordable and easy-to-use water treatment product aimed at reducing sickness and death caused by diarrheal diseases. P&G Purifier of Water has also been distributed to people living with HIV/AIDS and is available in retail outlets and pharmacies across Uganda.
PSI/Uganda also socially markets WaterGuard Tab, targeted at the general population in urban and peri-urban areas. A single sodium hypochlorite tablet can treat 20 liters of water; with each dispenser of WaterGuard containing 80 tablets at a cost of 70 cents. The WaterGuard Tab serves to increase the range of point-of-use treatment options available to our target populations including people living with HIV.
Condom social marketing
PSI/Uganda socially markets TRUST condoms in a bid to increase accessibility and availability of condoms across Uganda, especially in the peri-urban and rural communities. TRUST Condoms were rebranded in 2015 to include four new variants: TRUST Classic, TRUST Scented, TRUST Studded and TRUST Ribbed.
- The Pfizer Foundation
- The Maverick Collective
- The Bill and Melinda Gates Foundation
- Ministry of Health
- Reproductive Health Uganda
- Marie Stopes Uganda
- Marie Stopes International Uganda
- Various CBOs and NGOs
- Integrating Cervical Cancer Prevention Services with Voluntary Family Planning Programs
Over 311,000 women die from cervical cancer each year due to limited access to routine screening and early treatment. Many of the same countries struggling with high cervical cancer rates also have high unmet need for family planning (FP). As the global health community has prioritized both the reduction of unmet need for FP and, more recently, the global elimination of cervical cancer, there is an opportunity to review the evidence base and share practical considerations for integration of these services, with a view towards expanded access to products and services that improve women’s sexual and reproductive health.
- Association Between the Quality of Contraceptive Counseling and Method Continuation: Findings From a Prospective Cohort Study in Social Franchise Clinics in Pakistan and Uganda
This article presents evidence from social franchise clinics in Uganda and Pakistan showing that discontinuation rates for modern contraceptive use were lower among those women who received more information about their method (scored on the Method Information Index). This demonstrates the importance of quality of care in helping Sara to make informed decisions about her reproductive decision-making, and ultimately to be able to continue to use a method for which she has a need.
- Influencing Behaviour Change for Increased AYSRH Service Uptake Among Ugandan Youth Using Human Centered Design
- Improving Client Service Experience and Satisfaction Through E-System Based Support Supervision- The HNQIS Story
- Closing the gap on missed opportunity for provision of family planning to post abortion care (PAC) clients in private sector clinics
PSI Uganda through the Women’s Health Project, supports a franchise network of private clinics to offer integrated reproductive health services namely; family planning, PAC and cervical cancer screening.
- Strategies, Approaches and Tools Used to Introduce Next Generation Injectable Contraceptives in Resource Poor Settings
This workshop set out to identify different service delivery models share strategies and best practice, explore how DMPA-SC is being used within the wider method mix, and ultimately develop action plans for strengthening high quality DMPA-SC programming and implementation in participants’ respective countries.
- Do anti‑malarials in Africa meet quality standards? The market penetration of non quality‑assured artemisinin combination therapy in eight African countries
This paper uses national and sub-national medicine outlet surveys conducted in eight study countries (Benin, Kinshasa and Kantanga [Democratic Republic of the Congo, DRC], Kenya, Madagascar, Nigeria, Tanzania, Uganda and Zambia) between 2009 and 2015 to describe the non-QAACT market and to document trends in availability and distribution of non-QAACT in the public and private sector.
- Quality Issues with Malaria Rapid Diagnostic Test Accessories and Buffer Packaging: Findings from a 5‑Country Private Sector Project in Africa
This paper describes quality problems with buffer and accessories encountered in a project promoting private sector malaria rapid diagnostic test use in five African countries and suggests steps to avoid or more rapidly identify and resolve such problems.
- Ugandan Women’s View of the IUD: Generally Favorable but Many Have Misperceptions About Health Risks
This paper presents the results of a cross-sectional survey among 1,505 WRA exiting public and private health facilities in Uganda. We collected information on women’s attitudes, knowledge, and beliefs about the IUD, as well as their perceptions about its availability.
- Webinar: Stimulating the Market for Malaria RDTs in the Private Sector
PSI, UNITAID, Malaria Consortium, FIND, and JHSPH held a webinar to discuss leveraging the power of the private sector to transform the mRDT market in support of universal access to malaria diagnostics.